Discover MabDesign
MabDesign, the French association of the industrial sector of biomedicines, aims to support, structure, federate and increase the visibility of the industrial sector of biological medicines.

Access our network
Join the MabDesign network to take advantage of all the advantages and opportunities offered.

Develop your skills
Consult and register for our next training courses in order to acquire new expertise.

Explore our business services
The field of therapeutic antibodies and immunotherapy is growing rapidly. The French industrial ecosystem is rich in innovative companies with considerable potential. MabDesign’s mission is to support them in their development in France and abroad.

Upcoming events
Add your title here
23
Mar.
March 23-25, 2026
Partner Event
25
Mar.
March 25-26, 2026
Partner Event
02
Apr.
2 avril, 2026
Webinar
23
Apr.
Thursday 23 April, 2026
Webinar
28
Apr.
28-30 April, 2026
Partner Event
28
Apr.
April 28-30 2026
Partner Event
Our News

Cell Therapies
10 March 2026
MabDesign’s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of cell therapies.

Therapeutic antibodies
18 February 2026
MabDesign’s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.

ZOOM ON - Gensensor
12 February 2026
For five years, GenSensor has been on a mission to help bioproducers better understand and control what happens inside their fermenters and bioreactors, through cutting-edge biomarker monitoring
GenSampler® is the next step in that journey: a fully automated sampling system that seamlessly integrates aseptic sampling and sample preparation, unlocking the full potential of advanced analytics
OUR BOARD OF DIRECTORS





































































































































































































































































































































































































